Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Jeevan Scientific Technology had a gross margin of 92.38% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Jeevan Scientific Technology Gross Margin % Related Terms
Jeevan Scientific Technology Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:538837 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Jeevan Scientific Technology's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeevan Scientific Technology Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jeevan Scientific Technology's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Jeevan Scientific Technology's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Jeevan Scientific Technology (BOM:538837) has a Gross Margin % of 92.38% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Jeevan Scientific Technology and its competitors. This is near median its historical median of 91.79. Over the past decade, Jeevan Scientific Technology's Gross Margin % has ranged from 45.95 to 98.65. According to the industry distribution chart, Jeevan Scientific Technology ranks #94 out of 733 companies in the Biotechnology industry, placing it in the top 12.8%.
Is Jeevan Scientific Technology's Gross Margin % too high?
Jeevan Scientific Technology's current Gross Margin % of 92.38% is near median its 10-year median of 91.79. Over the past 10 years, this metric has ranged from a low of 45.95 to a high of 98.65. The Biotechnology industry median Gross Margin % is 60.90. Jeevan Scientific Technology's value of 92.38% is 51.7% above this industry median. Based on the distribution chart, Jeevan Scientific Technology ranks #94 out of 733 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Jeevan Scientific Technology has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jeevan Scientific Technology's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jeevan Scientific Technology ranks #94 out of 733 companies for Gross Margin %. This places Jeevan Scientific Technology in the top 13% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 60.90. Jeevan Scientific Technology's value of 92.38% is 51.7% above this benchmark. Historically, Jeevan Scientific Technology's own Gross Margin % has ranged from 45.95 to 98.65 over the past decade. While the company's 10-year median is 91.79 vs. the industry median of 60.90, Jeevan Scientific Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeevan Scientific Technology's current Gross Margin % of 92.38% is 51.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Jeevan Scientific Technology and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeevan Scientific Technology's current Gross Margin % is 92.38%, which is near median its own 10-year median of 91.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeevan Scientific Technology stock overvalued right now?
Based on GuruFocus' analysis, Jeevan Scientific Technology (BOM:538837) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹61.75, compared to a current price of ₹72.77 — trading 17.8% above its estimated fair value. The current Gross Margin % is 92.38%, which is near median its 10-year median of 91.79 and 51.7% above the Biotechnology industry median of 60.90. Jeevan Scientific Technology's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Jeevan Scientific Technology (BOM:538837), the current Gross Margin % is 92.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeevan Scientific Technology (BOM:538837) Overvalued in 2026?
Based on GuruFocus' analysis, Jeevan Scientific Technology stock appears to be overvalued.
The current stock price of ₹72.77 is trading 17.8% above its estimated GF Value™ of ₹61.75.
GuruFocus considers Jeevan Scientific Technology to be Modestly Overvalued.
Key valuation signals for BOM:538837:
Gross Margin %: 92.38% (near median its 10-year median of 91.79)
GF Value™: ₹61.75 vs. price of ₹72.77 (17.8% above fair value)
Industry Position: 51.7% above the Biotechnology median (#94 of 733)
No single metric tells the full story. See the BOM:538837 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeevan Scientific Technology Ltd is an India-based company engaged in providing clinical research and data management services. Jeevan Scientific is an independent clinical contract research organization, offering reliable, cost-effective, and technology-driven clinical research solutions to various clients across the globe. Its services offer high-value testing services, including bioanalytical services for small and large molecules, ranging across generics, biosimilars, and other new drugs. It operates in a single segment, namely clinical research services.
65GF Score
Get the complete analysis for BOM:538837
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538837 has been successfully added to your 
